Skip to main content
. 2013 Feb 19;8(2):e55922. doi: 10.1371/journal.pone.0055922

Figure 6. Schematic model of the enhancement of Apo2L/TRAIL sensitivity by apigenin.

Figure 6

Apigenin binds and inhibits ANT2. Inhibition of ANT2 augments Apo2L/TRAIL sensitivity via upregulation of DR5.